Stockreport

Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing

Psyence Biomedical Ltd. - Ordinary Shares  (PBM) 
PDF NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced the favorable outcome of the Nasd [Read more]